| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87428 |
|
2,833 |
2,731 |
$184K |
| 71046 |
Radiologic examination, chest; 2 views |
2,273 |
2,135 |
$98K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,383 |
1,345 |
$57K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
714 |
688 |
$47K |
| 73630 |
|
429 |
410 |
$39K |
| 73610 |
|
366 |
356 |
$35K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,916 |
1,774 |
$31K |
| 87081 |
|
1,618 |
1,486 |
$30K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
315 |
252 |
$24K |
| 87077 |
|
509 |
479 |
$13K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
204 |
199 |
$10K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
221 |
210 |
$9K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
221 |
210 |
$9K |
| 87088 |
|
381 |
356 |
$9K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
14 |
13 |
$7K |
| 87186 |
|
287 |
282 |
$7K |
| 73130 |
|
43 |
43 |
$4K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
157 |
152 |
$3K |
| 73110 |
|
27 |
27 |
$3K |
| 80053 |
Comprehensive metabolic panel |
84 |
84 |
$2K |
| 86317 |
|
42 |
28 |
$2K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
28 |
14 |
$2K |
| 73562 |
|
13 |
12 |
$1K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
37 |
36 |
$1K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
60 |
48 |
$1K |
| 87660 |
|
26 |
25 |
$959.04 |
| 87480 |
|
26 |
25 |
$959.04 |
| 87469 |
|
14 |
14 |
$921.20 |
| 87484 |
|
14 |
14 |
$921.20 |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$823.32 |
| 87510 |
|
13 |
12 |
$466.40 |
| 87486 |
|
14 |
13 |
$453.32 |
| 87581 |
|
14 |
13 |
$453.32 |
| 87015 |
|
12 |
12 |
$187.73 |